Literature DB >> 20228868

The Treatment of Obesity and Its Co-occurrence with Substance Use Disorders.

Katherine A Vanbuskirk1, Marc N Potenza.   

Abstract

Obesity and binge eating disorder are detrimental health conditions that are associated with lower qualities of life. Individuals with obesity often face societal discrimination and frequently experience related medical disorders such as diabetes, hypertension, and hyperlipidemia. Current research suggests neurobiological similarities between obesity, binge eating disorder, and substance dependence. In addition, behavioral similarities link the two conditions; obese and substance dependent individuals often report similar features such as loss of control towards food or substances, respectively, and cravings. Treatment options for obesity have begun to use this information to formulate pharmacological and therapeutic interventions that may provide greater results for weight loss and decreased binge frequency. Similarly, treatment approaches to substance addictions should consider aspects of weight management. Findings from research and treatment studies are presented with the aim of reviewing the current literature of obesity within the context of an addiction framework and providing information on empirically supported approaches to the treatment of co-occurring obesity and substance addiction.

Entities:  

Keywords:  comorbidity; obesity; substance use disorders

Year:  2010        PMID: 20228868      PMCID: PMC2835148          DOI: 10.1097/ADM.0b013e3181ce38e7

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  123 in total

Review 1.  Systematic review and meta-analysis of combination therapy for smoking cessation.

Authors:  Sima D Shah; Lori A Wilken; Susan R Winkler; Swu-Jane Lin
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Sep-Oct

2.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

3.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  [Tobacco smoking and other negative lifestyle behaviors among economically active individuals].

Authors:  Dorota Kaleta; Teresa Makowiec-Dabrowska; Kinga Polańska; Elzbieta Dziankowska-Zaborszczyk; Wojciech Drygas
Journal:  Med Pr       Date:  2009       Impact factor: 0.760

6.  Review and meta-analysis of pharmacotherapy for binge-eating disorder.

Authors:  Deborah L Reas; Carlos M Grilo
Journal:  Obesity (Silver Spring)       Date:  2008-09       Impact factor: 5.002

7.  The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

Authors:  Daniela Cota; Giovanni Marsicano; Matthias Tschöp; Yvonne Grübler; Cornelia Flachskamm; Mirjam Schubert; Dorothee Auer; Alexander Yassouridis; Christa Thöne-Reineke; Sylvia Ortmann; Federica Tomassoni; Cristina Cervino; Enzo Nisoli; Astrid C E Linthorst; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

Review 8.  Medicinal marijuana: a comprehensive review.

Authors:  R J Gurley; R Aranow; M Katz
Journal:  J Psychoactive Drugs       Date:  1998 Apr-Jun

9.  High sugar intake in a group of women on methadone maintenance in south western Sydney, Australia.

Authors:  D Zador; P M Lyons Wall; I Webster
Journal:  Addiction       Date:  1996-07       Impact factor: 6.526

10.  A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder.

Authors:  Denise E Wilfley; R Robinson Welch; Richard I Stein; Emily Borman Spurrell; Lisa R Cohen; Brian E Saelens; Jennifer Zoler Dounchis; Mary Ann Frank; Claire V Wiseman; Georg E Matt
Journal:  Arch Gen Psychiatry       Date:  2002-08
View more
  12 in total

1.  Explaining Excessive Weight Gain during Early Recovery from Addiction.

Authors:  Nisha C Gottfredson; Rebeccah L Sokol
Journal:  Subst Use Misuse       Date:  2018-12-21       Impact factor: 2.164

2.  Co-occurrence of obesity and patterns of alcohol use associated with elevated serum hepatic enzymes in US adults.

Authors:  James Tsai; Earl S Ford; Guixiang Zhao; Chaoyang Li; Kurt J Greenlund; Janet B Croft
Journal:  J Behav Med       Date:  2011-05-28

3.  Pharmacotherapies for Overeating and Obesity.

Authors:  S Yarnell; M Oscar-Berman; Nm Avena; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-04-01

4.  Cardiorespiratory fitness and body composition of stimulant users: A baseline analysis of the STRIDE cohort.

Authors:  Mark Stoutenberg; Chad D Rethorst; Denise C Vidot; Tracy L Greer; Madhukar H Trivedi
Journal:  J Subst Abuse Treat       Date:  2017-05-10

5.  Group-based strategies for stress reduction in methadone maintenance treatment: what do patients want?

Authors:  Declan T Barry; Mark Beitel; Timothy Breuer; Christopher J Cutter; Jonathan Savant; Skye Peters; Richard S Schottenfeld; Bruce J Rounsaville
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

Review 6.  Neuroscience of behavioral and pharmacological treatments for addictions.

Authors:  Marc N Potenza; Mehmet Sofuoglu; Kathleen M Carroll; Bruce J Rounsaville
Journal:  Neuron       Date:  2011-02-24       Impact factor: 17.173

7.  Changes in gene expression and sensitivity of cocaine reward produced by a continuous fat diet.

Authors:  M Carmen Blanco-Gandía; Auxiliadora Aracil-Fernández; Sandra Montagud-Romero; Maria A Aguilar; Jorge Manzanares; José Miñarro; Marta Rodríguez-Arias
Journal:  Psychopharmacology (Berl)       Date:  2017-04-29       Impact factor: 4.530

8.  Marijuana's Influence on Pain Scores, Initial Weight Loss, and Other Bariatric Surgical Outcomes.

Authors:  Frank L Bauer; William T Donahoo; Harris W Hollis; Adam G Tsai; Brian J Pottorf; Jason M Johnson; Lori J Silveira; Farah A Husain
Journal:  Perm J       Date:  2018

Review 9.  Similarities in alcohol and opioid withdrawal syndromes suggest common negative reinforcement mechanisms involving the interoceptive antireward pathway.

Authors:  Sean J O'Sullivan; James S Schwaber
Journal:  Neurosci Biobehav Rev       Date:  2021-02-26       Impact factor: 9.052

10.  The skinny on cocaine: insights into eating behavior and body weight in cocaine-dependent men.

Authors:  Karen D Ersche; Jan Stochl; Jeremy M Woodward; Paul C Fletcher
Journal:  Appetite       Date:  2013-08-03       Impact factor: 3.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.